Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Leamon

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Surgery|November 12, 2013
Expression of functional folate receptors by human parathyroid cellsCollin J Weber, Susan Müller, Susan A Safley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2020
Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugateIontcho R Vlahov, Longwu Qi, Hari Krishna R Santhapuram, et al.
Bioconjugate Chemistry|December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and ConjugatesIontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 28, 2010
Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modificationsChristopher P Leamon, Joseph A Reddy, Patrick J Klein, et al.
Scientific Reports|July 31, 2020
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agentJoseph A Reddy, Melissa Nelson, Christina Dircksen, et al.
Cancer Research|December 4, 2012
Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.
Molecular Cancer Therapeutics|June 4, 2016
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
Frontiers in Oncology|April 4, 2019
Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric MalignanciesYingjuan J Lu, Haiyan Chu, Leroy W Wheeler, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Surgery|November 12, 2013
Expression of functional folate receptors by human parathyroid cellsCollin J Weber, Susan Müller, Susan A Safley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2020
Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugateIontcho R Vlahov, Longwu Qi, Hari Krishna R Santhapuram, et al.
Bioconjugate Chemistry|December 7, 2017
Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and ConjugatesIontcho R Vlahov, Longwu Qi, Paul J Kleindl, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 28, 2010
Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modificationsChristopher P Leamon, Joseph A Reddy, Patrick J Klein, et al.
Scientific Reports|July 31, 2020
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agentJoseph A Reddy, Melissa Nelson, Christina Dircksen, et al.
Cancer Research|December 4, 2012
Targeting folate receptors to treat invasive urinary bladder cancerDeepika Dhawan, José A Ramos-Vara, James F Naughton, et al.
Molecular Cancer Therapeutics|June 4, 2016
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to VintafolideAmy D Guertin, Jennifer O'Neil, Alexander Stoeck, et al.
Oncotarget|January 18, 2019
Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinomaNicholas M Szigetvari, Deepika Dhawan, José A Ramos-Vara, et al.
Frontiers in Oncology|April 4, 2019
Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric MalignanciesYingjuan J Lu, Haiyan Chu, Leroy W Wheeler, et al.
Pageof 8